Literature DB >> 22763943

A simple Bayesian decision-theoretic design for dose-finding trials.

Shenghua Kelly Fan1, Ying Lu, You-Gan Wang.   

Abstract

A flexible and simple Bayesian decision-theoretic design for dose-finding trials is proposed in this paper. In order to reduce the computational burden, we adopt a working model with conjugate priors, which is flexible to fit all monotonic dose-toxicity curves and produces analytic posterior distributions. We also discuss how to use a proper utility function to reflect the interest of the trial. Patients are allocated based on not only the utility function but also the chosen dose selection rule. The most popular dose selection rule is the one-step-look-ahead (OSLA), which selects the best-so-far dose. A more complicated rule, such as the two-step-look-ahead, is theoretically more efficient than the OSLA only when the required distributional assumptions are met, which is, however, often not the case in practice. We carried out extensive simulation studies to evaluate these two dose selection rules and found that OSLA was often more efficient than two-step-look-ahead under the proposed Bayesian structure. Moreover, our simulation results show that the proposed Bayesian method's performance is superior to several popular Bayesian methods and that the negative impact of prior misspecification can be managed in the design stage.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22763943     DOI: 10.1002/sim.5438

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  2 in total

1.  A curve free Bayesian decision-theoretic design for phase Ia/Ib trials considering both safety and efficacy outcomes.

Authors:  Shenghua Fan; Bee Leng Lee; Ying Lu
Journal:  Stat Biosci       Date:  2020-03-26

2.  A nonparametric Bayesian continual reassessment method in single-agent dose-finding studies.

Authors:  Niansheng Tang; Songjian Wang; Gen Ye
Journal:  BMC Med Res Methodol       Date:  2018-12-18       Impact factor: 4.615

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.